Boston-Power Banks Big Bucks, Follica Sprouts From Stem-Cell Science, NetApp Nabs Onaro, & More

The new year got off to a good start last week for Boston-area tech firms. Even with the abbreviated work week there were plenty of deals for us to discuss. —Needham, MA’s HiWired announced it has raised $9 million in a Series B financing led by North Hill Ventures and joined by Sigma Partners and … Continue reading “Boston-Power Banks Big Bucks, Follica Sprouts From Stem-Cell Science, NetApp Nabs Onaro, & More”

frevvo LLC Receives $500,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=48e0dd70-e5a7-44ea-977b-5181f932d97c&Preview=1 Date 1/7/2008 Company Name frevvo LLC Mailing Address 82 Anderson Rd Wallingford, CT 06492 Company Description frevvo’s Live Forms Designer leverages Ajax technologies to easily create rich, dynamic, Web 2.0 forms using just a browser. These forms work with real business applications and provide a rich user experience far beyond typical … Continue reading “frevvo LLC Receives $500,000 New Round”

PeerApp Raises $3 Million for P2P Video

PE Week Wire reported this week that PeerApp, the Newton, MA-based peer-to-peer (P2P) video distribution startup that we covered on December 12, has collected $3 million in new venture funding. The round was led by existing investors Pilot House Ventures, Evergreen, and Cedar Fund. The company’s proprietary server technology helps Internet service providers mitigate the … Continue reading “PeerApp Raises $3 Million for P2P Video”

One Laptop Foundation Blasts Intel, Says World’s Children are Mission, Not Market

Apparently, the global village ain’t big enough for both Intel and Nicholas Negroponte. The giant chipmaker said Thursday it had pulled out of Negroponte’s Cambridge-based One Laptop Per Child Foundation (OLPC), which is building a sub-$200 laptop for use by children in developing countries. Intel, with its $300-ish Classmate notebook computer, has its eye on … Continue reading “One Laptop Foundation Blasts Intel, Says World’s Children are Mission, Not Market”

Onaro to be Acquired by NetApp for a Reported $120 Million

Boston-based storage software provider Onaro, whose customer list includes Jet Blue Airways, State Street Global Advisors, and Wyeth Pharmaceuticals, will be acquired by California data management firm NetApp (NASDAQ:[[ticker:NTAP]]), the companies announced yesterday. Terms of the deal were not disclosed, but a report in TechCrunch, citing Israeli reports (Onaro’s roots are apparently in Israel), put … Continue reading “Onaro to be Acquired by NetApp for a Reported $120 Million”

Vertex Falls On Hepatitis Drug Delay Reports

Shares of Cambridge, MA-based Vertex Pharmaceuticals (NASDAQ:[[ticker:VRTX]]) sagged again this morning after falling 7 percent yesterday on word that a prominent analyst had downgraded the stock in light of flawed trials that could delay the debut of its hepatitis C drug candidate by as much as two years. The Associated Press reported on Thursday that … Continue reading “Vertex Falls On Hepatitis Drug Delay Reports”

Spark Capital Puts $5 Mil into 5min

“How-to” is one of the hottest sub-genres in Internet video, with several startups such as Austin, TX-based Expert Village, Barcelona’s Sclipo, and Los Angeles-based Videojug springing up specifically to serve the do-it-yourself crowd. But when the guys at Boston’s Spark Capital decided to invest in a how-to video company, they wound up going all the … Continue reading “Spark Capital Puts $5 Mil into 5min”

Gone Today, Hair Tomorrow—Follica Raises Funds to Begin Human Trial of Baldness Treatment

Call it a hair-raising event. Follica, a Boston startup out to develop novel ways of treating and even curing baldness and other hair-follicle disorders, today announced it had completed a $5.5 million Series A financing round. The round was led by Interwest Partners of Dallas and Menlo Park, CA, and joined by founding investor PureTech … Continue reading “Gone Today, Hair Tomorrow—Follica Raises Funds to Begin Human Trial of Baldness Treatment”

The Telephone Gambit: Did Bell Steal His Legendary Invention? (Part Two)

Editor’s note: This marks the second and final installment of a unique profile—a detective story, really—of a Boston-area entrepreneur and his famous invention. The story was excerpted from Xconomy contributing writer Seth Shulman’s The Telephone Gambit: Chasing Alexander Graham Bell’s Secret (W. W. Norton 2008), which will be officially released on Monday. The first installment … Continue reading “The Telephone Gambit: Did Bell Steal His Legendary Invention? (Part Two)”

Follica Inc. Garners $5,500,000 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=de681d7d-1b40-4c96-924a-68d8ada5767e&Preview=1 Date 1/4/2008 Company Name Follica Inc. Mailing Address 222 Berkeley Street Boston, MA 02116 Company Description Follica Inc., a privately held medical device company, was co-founded by PureTech Ventures and a group of world renowned experts in hair follicle biology and medicine. In addition to hair loss, Follica has intellectual property … Continue reading “Follica Inc. Garners $5,500,000 Series A Financing Round”

After Missing Key Milestones, N2N Calls it the End; E-Commerce Startup Had Raised $30 Million

N2N Commerce, a Cambridge, MA-based e-commerce company that raised $30 million from General Catalyst Partners and Limited Brands (from which it spun off), laid off essentially all its staff just before Christmas and is ceasing operations, says a source close to the company, confirming a report yesterday in TechCrunch. The source also says the 18-month-old … Continue reading “After Missing Key Milestones, N2N Calls it the End; E-Commerce Startup Had Raised $30 Million”

Boston-Power Recharges with Big Investment for Safer, Longer-lasting Lithium-Ion Batteries

As many of our readers know, the X in Xconomy stands for “exponential,” referring to the rapid rate at which technologies such as semiconductors and genomics evolve and in turn transform our economy and our daily lives. Unfortunately, the batteries in the information devices we carry everywhere these days aren’t one of those exponential technologies. … Continue reading “Boston-Power Recharges with Big Investment for Safer, Longer-lasting Lithium-Ion Batteries”

New CEO for T2 Biosystems

Cambridge’s T2 Biosystems, a developer of portable medical diagnostic products combining nanotechnology and miniaturized magnetic resonance imaging technology, today announced that John McDonough has been named its new CEO. McDonough, previously president of medical diagnostics and devices company Cytyc Development, will also join T2’s board of directors.

Tempo Steps Up The Funding Pace

Tempo Pharmaceuticals, a Cambridge, MA-based biopharmaceutical startup that’s developing treaments for cancer, and autoimmune and inflammatory diseases based on nanoparticles that can release two different drugs at different rates, announced today that it has closed an $8.1 million Series B financing round. New investor Bessemer Venture Partners of Wellesley, MA, joined previous investors Polaris Venture … Continue reading “Tempo Steps Up The Funding Pace”

Obesity Startup Gelesis Gobbles Up $16M in Financing

Gelesis, a Boston-based biotech startup focusing on obesity, announced this morning that it has raised $16 million in its first institutional financing. The round was led by healthcare investment giant OrbiMed Advisors of New York and joined by Australia’s Queensland BioCapital Funds and others. It comes on top of a $900,000 seed investment from PureTech … Continue reading “Obesity Startup Gelesis Gobbles Up $16M in Financing”

The Telephone Gambit: Did Bell Steal His Legendary Invention?

Editor’s note: Just about everyone knows the story of Alexander Graham Bell and his invention of the telephone—and those famous words uttered in the inventor’s Boston workshop to his assistant, Thomas Watson. But what if the whole history of the telephone was rooted in a lie? A few years ago, when I walked into the … Continue reading “The Telephone Gambit: Did Bell Steal His Legendary Invention?”

Gelesis, Inc. Receives $16,000,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=503ee5fa-ccde-481d-88a2-4c402cf9340e&Preview=1 Date 1/3/2008 Company Name Gelesis, Inc. Mailing Address 222 Berkeley St Boston, MA 02116 Company Description Gelesis is a Research and Development company for the treatment of obesity. Website Undisclosed Transaction Type Venture Equity Transaction Amount $16,000,000 Transaction Round Series A Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture … Continue reading “Gelesis, Inc. Receives $16,000,000 Series A Funding Round”

Boston-Power, Inc. Lands $45,000,000 Series C Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=280c6206-cc90-4a60-aded-6434c81d8a36&Preview=1 Date 1/3/2008 Company Name Boston-Power, Inc. Mailing Address 2200 West Park Drive Westborough, MA 01581 Company Description Boston-Power, Inc. ™ is an emerging portable power company answering the call for safer, longer lasting Lithium-ion batteries – today. Website http://www.boston-power.com Transaction Type Venture Equity Transaction Amount $45,000,000 Transaction Round Series C Proceeds … Continue reading “Boston-Power, Inc. Lands $45,000,000 Series C Round”

PeerApp Receives $3,000,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=47cacd91-7fd0-4cee-b866-8cd253c822a7&Preview=1 Date 1/3/2008 Company Name PeerApp Mailing Address 375 Elliot Street Newton Upper Falls, MA 02464 Company Description PeerApp is a leading supplier of peer-to-peer infrastructure solutions for Internet service providers. PeerApp solutions reduce Peer-to-Peer (P2P) related bandwidth costs without impacting subscriber experience; support service provider network/subscriber growth and enable new revenue-generating … Continue reading “PeerApp Receives $3,000,000 New Financing”

Tempo Pharmaceuticals Garners $8,000,000 Series B Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=95c37f3a-5181-4387-a0d7-ffb8d3044d6e&Preview=1 Date 1/3/2008 Company Name Tempo Pharmaceuticals Mailing Address 161 First Street Cambridge, MA 02142 Company Description Tempo Pharmaceuticals is a private biopharmaceutical company focused on the development of novel, nanotechnology-based therapeutics in the areas of oncology, autoimmune and inflammatory diseases. The Company has assembled a world-class management team, board of directors … Continue reading “Tempo Pharmaceuticals Garners $8,000,000 Series B Financing”

Network Appliance Inc. Acquires Onaro for Undisclosed Sum

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=81206330-0ad5-4583-9cfa-56c25ac8faee&Preview=1 Date 1/3/2008 Company Name Onaro Mailing Address 500 Harrison Ave Boston, MA 02118 Company Description While datacenter automation has already brought significant benefits to server and network management, it has largely bypassed networked storage. Networked storage can no longer be bypassed by datacenter automation. Onaro enables corporations to successfully extend datacenter … Continue reading “Network Appliance Inc. Acquires Onaro for Undisclosed Sum”

Calistoga Pharmaceuticals Receives $5,200,000 Series A Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c8a40def-dd2e-4d4f-a0da-fcd9af496d89&Preview=1 Date 1/3/2008 Company Name Calistoga Pharmaceuticals Mailing Address 2101 – 4th Avenue Seattle, WA 98121 Company Description Calistoga Pharmaceuticals, is developing a drug candidate acquired from Icos that has potential to treat various forms of cancer, according to the company. Icos, maker of the impotence drug Cialis, was acquired by its … Continue reading “Calistoga Pharmaceuticals Receives $5,200,000 Series A Financing Round”

Venture-Backed IPOs Soared in 2007; Boston Led the Way in Fourth Quarter

A wave of initial public offerings in the fourth quarter of 2007—led by companies in Boston and San Jose—helped make last year the best IPO year for venture-backed firms since 2004, according to a report released today by Thomson Financial and the National Venture Capital Association. The fourth quarter saw 31 venture-backed IPOs (totaling $3 … Continue reading “Venture-Backed IPOs Soared in 2007; Boston Led the Way in Fourth Quarter”

Analog Devices Completes $184 Million Sale of Business Line

Analog Devices (NYSE: [[ticker:ADI]]) announced today that it has completed the $184 million sale, announced last November, of its CPU voltage regulation and PC thermal monitoring business to ON Semiconductor of Phoenix. The divestiture is part of Norwood, MA-based Analog’s efforts to transition its power management portfolio to high-performance products that better complement its signal-processing … Continue reading “Analog Devices Completes $184 Million Sale of Business Line”

Sepracor Licenses Epilepsy Drug

Marlborough, MA-based Sepracor, maker of the insomnia drug Lunesta, announced today that it has signed an exclusive licensing deal with Bial covering development and commercialization of the Portuguese company’s anti-epileptic compound BIA 2-093 in Canada and the United States. Under the terms of the agreement, Bial will receive $75 million up front and is eligible … Continue reading “Sepracor Licenses Epilepsy Drug”

High Financing for HiWired

HiWired, a Needham, MA-based provider of IT support and services for consumers and small businesses, announced today that it has received $9 million in a Series B financing. The round was led by North Hill Ventures and includes Series A investors Sigma Partners and Kodiak Venture Partners. HiWired was founded in 2004 by Singu Srinivas … Continue reading “High Financing for HiWired”

InCytu’s Betting that On-the-Spot Body Repair Will Succeed Where Traditional Tissue Engineering Has Not

With its aim of growing replacements for injured or ailing body parts, tissue engineering is a field that at first seemed spectacularly promising. (Anyone remember the mouse with a human ear growing on its back?) But it has ended up being a bit of a boondoggle. Although researchers have made important scientific advances in areas … Continue reading “InCytu’s Betting that On-the-Spot Body Repair Will Succeed Where Traditional Tissue Engineering Has Not”

EMC, Cubist, and Others Do Some Last-Minute Shopping, Dyax Readies for an Offering, Millennium Sees a Payday, and More

It’s been relatively quiet since last we rounded up (on Christmas Eve), but a few local tech companies managed to ink a deal or two—mainly acquisitions—in the waning hours of 2007. —Dyax (NASDAQ: [[ticker:DYAX]]) filed a shelf registration statement that, when declared effective by the SEC, will give the Cambridge, MA-based biotech the ability to … Continue reading “EMC, Cubist, and Others Do Some Last-Minute Shopping, Dyax Readies for an Offering, Millennium Sees a Payday, and More”

You Get What You Celebrate

People think we have an education crisis, and that fixing some or all of the elements of “supply”—more teachers, more computers, more books, more standards, more tests, etc.— will solve the problem. My view is that we don’t have an education crisis, and we don’t have a supply crisis—we have a “demand” crisis. We need … Continue reading “You Get What You Celebrate”

HiWired Obtains $9,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ade94954-4663-40f5-be13-fcee15961116&Preview=1 Date 1/2/2008 Company Name HiWired Mailing Address 117 Kendrick Street Needham, MA 02494 Company Description HiWired partners with electronics manufacturers, retailers and Internet providers to offer remote technology management services to consumers and small businesses. Website http://www.hiwired.com Transaction Type Venture Equity Transaction Amount $9,000,000 Transaction Round Series B Proceeds Purposes HiWired … Continue reading “HiWired Obtains $9,000,000 Series B Funding Round”

UBmatrix, Inc. Receives $8,000,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d93f95fd-6a63-46e5-95c2-3c1638f0af2a&Preview=1 Date 1/2/2008 Company Name UBmatrix, Inc. Mailing Address 803 Kirkland Avenue Kirkland, WA 98033-6318 Company Description UBmatrix provides an XBRL-based platform and products for the full lifecycle of design, development, and deployment of applications that collect, validate, aggregate, report or exchange information. Website http://www.ubmatrix.com Transaction Type Venture Equity Transaction Amount $8,000,000 … Continue reading “UBmatrix, Inc. Receives $8,000,000 Series B Round”

Friendent, Inc. Secures $50,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=370a5faa-7018-42f4-9a6a-03facda2ea05&Preview=1 Date 12/31/2007 Company Name Friendent, Inc. Mailing Address 832 Quinnipiac Avenue New Haven, CT 06513 Company Description The company provides an Internet-related service. Website http://www.friendent.com Transaction Type Venture Equity Transaction Amount $50,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor First Round Capital Venture Investor … Continue reading “Friendent, Inc. Secures $50,000 New Financing Round”

Q1 Labs, Inc. Lands $9,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=de3db233-0aea-416e-a6a6-0f028e45df7a&Preview=1 Date 12/31/2007 Company Name Q1 Labs, Inc. Mailing Address 890 Winter Street Waltham, MA 02451 Company Description Q1 Labs is a network security management company. Website http://www.q1labs.com Transaction Type Venture Equity Transaction Amount $9,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Menlo Ventures Venture … Continue reading “Q1 Labs, Inc. Lands $9,000,000 New Round”

Adesso Systems Garners $1,063,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f221d3e5-7737-42ef-9fc7-125a700a7908&Preview=1 Date 12/31/2007 Company Name Adesso Systems Mailing Address One Liberty Square Boston, MA 02109 Company Description The company develops software solutions that enable people to organize information. Website http://www.adessosystems.com Transaction Type Venture Equity Transaction Amount $1,063,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Carlyle … Continue reading “Adesso Systems Garners $1,063,000 New Funding”

RuleStream Corporation Receives $514,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c8ec8c2-173c-40eb-9752-14d02e4eb076&Preview=1 Date 12/31/2007 Company Name RuleStream Corporation Mailing Address 301 Edgewater Place Wakefield, MA 01880 Company Description RuleStream’s enterprise software for knowledge capture and reuse allows manufacturers to accelerate product planning, design and production by more effectively aggregating and managing their Intellectual Property (IP) assets. RuleStream’s solutions help manufacturers engaged in Fabrication … Continue reading “RuleStream Corporation Receives $514,000 New Round”

InfraReDx, Inc. Secures $15,600,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d9155bdd-dd03-4f5c-a3ed-196ef2f11116&Preview=1 Date 12/31/2007 Company Name InfraReDx, Inc. Mailing Address 34 Third Avenue Burlington, MA 01803 Company Description The company has now developed a fiber-optic, catheter-based, near infrared (NIR) spectroscopy system designed to characterize the composition of coronary plaques in patients undergoing catheterization. This NIR system is currently being evaluated in a clinical … Continue reading “InfraReDx, Inc. Secures $15,600,000 New Funding Round”

Anexon, Inc. Lands $500,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=09bdb708-b6e3-4735-8d16-1bcb368d42c6&Preview=1 Date 12/31/2007 Company Name Anexon, Inc. Mailing Address Undisclosed Cambridge, MA 02142 Company Description The company develops therapeutics for cardiovascular disease. Website Undisclosed Transaction Type Venture Equity Transaction Amount $500,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor HealthCare Ventures Venture Investor Undisclosed

Virtual Goods Market, Inc. Obtains $2,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c243c851-ed9d-499e-a372-1f445f06bd9e&Preview=1 Date 12/31/2007 Company Name Virtual Goods Market, Inc. Mailing Address 13 Magazine Steet Cambridge, MA 02139 Company Description The company designs and sells virtual goods online. Website Undisclosed Transaction Type Venture Equity Transaction Amount $2,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor North Bridge … Continue reading “Virtual Goods Market, Inc. Obtains $2,000,000 New Round”

Keisense, Inc. Receives $500,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=091c0eac-7038-45a8-a7a9-226e1f8ec8e7&Preview=1 Date 12/31/2007 Company Name Keisense, Inc. Mailing Address 151 New Park Avenue Hartford, CT 01603 Company Description Keisense is a technology company, working at the forefront of user interface and data entry technologies for consumer electronic devices. Website http://www.keisense.com Transaction Type Venture Equity Transaction Amount $500,000 Transaction Round Undisclosed Proceeds Purposes … Continue reading “Keisense, Inc. Receives $500,000 New Financing”

CitySquares Online, Inc. Receives $450,000 New Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0358bf88-4f90-4e35-8254-23b2332aa1ec&Preview=1 Date 12/31/2007 Company Name CitySquares Online, Inc. Mailing Address 580 Harrison Ave, 4th Floor Boston, MA 02118 Company Description We are most certainly, first and foremost, and undoubtedly about local businesses and local communities. We’re about your neighborhood, and where you get your hair cut, meet your friends for coffee, have … Continue reading “CitySquares Online, Inc. Receives $450,000 New Funding”

Dynogen Pharmaceuticals, Inc. Obtains $3,999,900 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0e75600f-61b9-4378-98d4-2400bd66e838&Preview=1 Date 12/31/2007 Company Name Dynogen Pharmaceuticals, Inc. Mailing Address 52 Second Avenue Waltham, MA 02451 Company Description Dynogen Pharmaceuticals, Inc., is a neuroscience-based drug discovery and development company targeting first-in-class and best-in-class therapies for genitourinary and gastrointestinal disorders. Website http://www.dynogenpharma.com Transaction Type Venture Equity Transaction Amount $3,999,900 Transaction Round Undisclosed Proceeds … Continue reading “Dynogen Pharmaceuticals, Inc. Obtains $3,999,900 New Round”

Hydrocision Secures New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=52d2b970-0e56-45c6-83b8-2e5ffcc58b45&Preview=1 Date 12/31/2007 Company Name Hydrocision Mailing Address 267 Boston Road North Billerica, MA 01862 Company Description HydroCision is the leading developer, manufacturer, and marketer of fluid-jet based surgical tools for the spine market. Incorporated in 1994, HydroCision s proprietary fluidjet technology is the basis of a new surgical modality leveraging compelling … Continue reading “Hydrocision Secures New Financing Round”

OmniSonics Medical Technologies Obtains $10,021,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5a369d81-d567-499c-8e01-39724a9879c9&Preview=1 Date 12/31/2007 Company Name OmniSonics Medical Technologies Mailing Address 66 Concord Street Wilmington, MA 01887 Company Description OmniSonics Medical Technologies, Inc. is a privately held medical device company focused on bringing breakthrough products for vascular occlusive disease to market Website http://www.omnisonics.com Transaction Type Venture Equity Transaction Amount $10,021,000 Transaction Round Undisclosed … Continue reading “OmniSonics Medical Technologies Obtains $10,021,000 New Funding Round”

Zafgen, Inc. Obtains $21,000,000 New Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9cfca319-e4e8-4c8f-b7ce-3af85652b7c1&Preview=1 Date 12/31/2007 Company Name Zafgen, Inc. Mailing Address 29 Newbury Street Boston, MA 02116 Company Description The company is developing novel therapeutics for the treatment of obesity. Website http://www.zafgen.com Transaction Type Venture Equity Transaction Amount $21,000,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. M&A Terms Venture Investor Atlas … Continue reading “Zafgen, Inc. Obtains $21,000,000 New Funding Round”

FitLinxx, Inc. Obtains $300,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=90269977-e6fd-49e0-b92f-3cb0956197ff&Preview=1 Date 12/31/2007 Company Name FitLinxx, Inc. Mailing Address 542 Westport Avenue, 2nd Floor Norwalk, CT 06851 Company Description FitLinxx is the endorsed industry standard and recognized global leader for providing technology that helps people reach their fitness goals. FitLinxx helps users exercise properly and stay motivated to stick with their fitness … Continue reading “FitLinxx, Inc. Obtains $300,000 New Financing Round”

Aveo Pharmaceuticals, Inc. Receives $5,499,600 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5898fb58-529a-45db-883f-3d6c03c3d0cc&Preview=1 Date 12/31/2007 Company Name Aveo Pharmaceuticals, Inc. Mailing Address 75 Sidney Street Cambridge, MA 02139 Company Description AVEO is a biopharmaceutical company focused on the discovery and development of novel cancer therapeutics. AVEO is developing a pipeline of targeted therapies which address major unmet medical needs in the field of oncology. … Continue reading “Aveo Pharmaceuticals, Inc. Receives $5,499,600 New Financing”